Preclinical studies have found that elevated expression of SPHK1 could result in tumor migration, invasiveness, and angiogenesis by several mechanisms, such as the SPHK1/miR-144-3p/FN1 and SPHK1/p-PAK axes [16, 17]. The gene discussed is SPHK1; the disease is neoplasm.